The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 2-(4-(10-hydroxy-9-oxo-10-(trifluoromethyl)-9,10-dihydroanthracen-1-yl)-1H-pyrazol-1-yl)propanoate ID: ALA4476749
PubChem CID: 155538525
Max Phase: Preclinical
Molecular Formula: C23H19F3N2O4
Molecular Weight: 444.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C(C)n1cc(-c2cccc3c2C(=O)c2ccccc2C3(O)C(F)(F)F)cn1
Standard InChI: InChI=1S/C23H19F3N2O4/c1-3-32-21(30)13(2)28-12-14(11-27-28)15-8-6-10-18-19(15)20(29)16-7-4-5-9-17(16)22(18,31)23(24,25)26/h4-13,31H,3H2,1-2H3
Standard InChI Key: QGLASXHMGWAPAQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
10.8340 -8.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4295 -7.8624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0205 -8.5655 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3108 -6.6365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3097 -7.4561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0177 -7.8650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0159 -6.2277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7246 -6.6329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7234 -7.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4319 -6.2214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1426 -6.6349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1410 -7.4520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8466 -7.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5543 -7.4524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5520 -6.6323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8458 -6.2278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4319 -5.4042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8439 -5.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4987 -4.9271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2447 -4.1502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4272 -4.1525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1766 -4.9302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6581 -3.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4757 -3.4513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4231 -9.2745 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.6512 -8.5707 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.2384 -9.2739 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.2546 -2.7342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8787 -4.1622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8899 -2.7469 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6959 -4.1687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0989 -4.8796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 10 1 0
9 2 1 0
2 12 1 0
11 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 2 0
22 18 1 0
20 23 1 0
23 24 1 0
1 25 1 0
1 26 1 0
1 27 1 0
23 28 1 0
24 29 1 0
24 30 2 0
29 31 1 0
31 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 444.41Molecular Weight (Monoisotopic): 444.1297AlogP: 4.02#Rotatable Bonds: 4Polar Surface Area: 81.42Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.63CX Basic pKa: 1.97CX LogP: 3.84CX LogD: 3.84Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.62Np Likeness Score: -0.46
References 1. Lee D, Pagire HS, Pagire SH, Bae EJ, Dighe M, Kim M, Lee KM, Jang YK, Jaladi AK, Jung KY, Yoo EK, Gim HE, Lee S, Choi WI, Chi YI, Song JS, Bae MA, Jeon YH, Lee GH, Liu KH, Lee T, Park S, Jeon JH, Lee IK, Ahn JH.. (2019) Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases., 62 (2): [PMID:30623649 ] [10.1021/acs.jmedchem.8b01168 ]